Biohackers measure, supplement, fast, cool, heat and optimize in pursuit of a longer life. The honest answer is that nobody has yet shown that biohackers outlive the rest of us.
Picture two people who would both like to see their hundredth birthday.
One wears a device that records every heartbeat and hour of sleep. Their kitchen resembles a small pharmacy. They track blood tests, restrict when they eat, plunge into cold water and follow the changing numbers on a biological-age report.
The other takes a daily walk, doesn’t smoke, sleeps at roughly the same time each night and sees a doctor when something is wrong.
Which one will live longer?
Science can’t yet tell us. That isn’t because longevity researchers are uninterested. It’s because a human life is a remarkably difficult experiment.
There’s no spare copy of you who can live the same life without the supplements, sensors and cold plunges. Biohacking is also a young and loosely defined movement. No large, long-running study has compared self-described biohackers with otherwise similar people and followed both groups until death.
So the direct answer is simple: we don’t know whether biohackers live longer.
The more useful answer requires asking what, exactly, they are doing.

What is a biohacker?
“Biohacking” can mean almost anything done to alter or measure the body.
At one end are habits a family doctor might recommend: exercise, nutritious food, adequate sleep and avoiding tobacco. Add a fitness tracker and a spreadsheet, and an ordinary health routine can begin to look like biohacking.
At the other end are off-label prescription drugs, large supplement combinations, extreme diets, frequent scans, unapproved cell products and treatments purchased from clinics far beyond the reach of good clinical evidence.
Placing all of this under one name creates confusion. A brisk walk and an experimental infusion are not two versions of the same bet. They come with very different evidence and very different risks.
The label tells us little. The intervention tells us much more.
The least futuristic “hacks” have the strongest evidence
If some biohackers eventually live longer, it may be because they adopted behaviors that were useful long before the word existed.
In a 2018 study, researchers combined data from two large US cohorts with national mortality records. They estimated that, at age 50, people who met five low-risk lifestyle criteria could expect substantially more years of life than people who met none. The criteria were never smoking, regular physical activity, a healthy diet, moderate alcohol intake and a healthy body weight.
The estimated difference was about 14 years for women and 12 years for men.
Those numbers came from observational data and statistical modelling. They don’t prove that copying five behaviors will add an exact number of candles to anyone’s birthday cake. Health, income, education and access to care can travel together. Still, the findings fit a much larger body of evidence.
Smoking offers an especially stark example. A major US study found that continuing smokers lost more than a decade of life expectancy compared with people who never smoked. Quitting greatly reduced that loss.
Regular movement also tracks with longer life. A pooled analysis of more than 650,000 adults found that even modest amounts of leisure-time physical activity were associated with added years of life after age 40.
None of this feels like science fiction. That’s partly why it’s easy to overlook.
The strange truth about the longevity world is that its most convincing tools are often the least exotic.
A younger blood test is not an extra year of life

Biohackers often use numbers as an early answer to a very late question.
Waiting to see who lives longer could take decades. Researchers therefore study cholesterol, blood pressure, inflammation, physical function and newer measures known as biological-age clocks. Some clocks examine chemical marks on DNA. Others combine ordinary clinical measurements into a single score.
These tools can be useful. They may reveal risk or help scientists test an idea more quickly. But a clock is a model, not a glimpse of your expiry date.
Different clocks can give different answers for the same intervention. In the CALERIE randomized trial, 220 healthy adults without obesity were assigned either to calorie restriction or to continue eating normally for two years. A later analysis found a small slowing on one DNA-based measure called DunedinPACE. Two other widely used clocks, PhenoAge and GrimAge, did not show significant change.
The trial didn’t establish that participants would live longer. It showed that a carefully studied intervention moved one experimental measure over two years.
Researchers are still working out how aging biomarkers should be validated. To stand in for lifespan, a marker must do more than predict who is at higher risk. Scientists need to know that changing the marker through an intervention reliably changes health or survival. That bridge has not yet been built for the tests commonly sold as biological age.
If your clock says you grew three years younger, time hasn’t started running backward. A calculation changed.
What about metformin, rapamycin and other longevity drugs?
Some biohackers take medicines that produced intriguing results in animals or were developed for a different human disease.
Rapamycin is a powerful example. It can extend lifespan in mice and acts on mTOR, a system involved in growth and nutrient sensing. Human studies have reported effects on certain immune, cardiovascular and skin-related measures. A 2024 systematic review also found major gaps: several organ systems had not been assessed, studies were generally short, and some participants with age-related diseases had more infections or higher blood lipids.
No trial has shown that rapamycin makes healthy people live longer.
Metformin has been used safely and effectively for many people with type 2 diabetes. Its possible role in healthy aging is far less certain. Much of the enthusiasm came from animal work and observational comparisons involving people with diabetes, where treating the disease itself can improve health. Reviews of the evidence have warned that a lifespan benefit for people without diabetes remains unproven.
The same caution applies to many supplements and experimental treatments. A plausible mechanism is a reason to conduct a study. It is not the result of that study.
Why personal experiments can fool us
Careful self-observation can teach a person about their habits. It is much less reliable for discovering whether an intervention slows aging.
Suppose you begin a new supplement and your sleep improves. The supplement may have helped. But perhaps you expected it to help, started going to bed earlier, drank less alcohol that week or simply had several unusually good nights.
Now imagine changing six supplements, a diet, an exercise plan and a sauna routine at once. Even if a blood result improves, there is no clean way to know why.
Scientists use control groups, random assignment and blinding because human beings are excellent storytellers. We can turn a rising score into proof of success and a falling one into a temporary adjustment. The story can become especially persuasive when it is about our own body.
Biohackers also tend to be unusual before they begin. Many have money, education, time, good medical access and intense motivation. If they fare better than the average person, those advantages could explain some or all of the difference.
Can measuring everything cause harm?
Measurement can uncover a treatable problem. It can also find harmless irregularities that lead to worry, repeat testing and invasive follow-up.
Our bodies are full of small departures from textbook perfection. The more often we look, the more of them we find.
Interventions bring a second kind of risk. Prescription drugs can have side effects and interactions. Large supplement stacks can contain excessive doses or ingredients that affect one another. The US Food and Drug Administration has warned that many marketed stem-cell and exosome products are unapproved, have not been shown to be safe or effective, and may pose serious safety concerns.
A person can therefore become healthier through attention while becoming less safe through intervention. The outcome depends on what is measured, what is done with the result and how good the evidence is.
So, do biohackers actually live any longer?
Perhaps some will. We don’t yet have the study that would show it.
Many biohackers exercise, avoid smoking, pay attention to sleep and manage known medical risks. Those choices are supported by decades of human evidence and could improve the odds of a longer, healthier life.
What hasn’t been demonstrated is that the biohacking package itself, especially its experimental drugs, elaborate supplement stacks and proprietary age scores, adds years beyond good preventive care and ordinary healthy behavior.
The most scientific biohacker may be the one willing to live with an unsatisfying result: promising is not proven, measurable is not necessarily meaningful, and a younger-looking number is not the same as a longer life.
There is wonder in the biology. A molecule first found in soil microbes can alter lifespan in a mouse. Chemical marks on DNA can contain an echo of age. Tiny sensors can follow the sleeping heart through the night.
But wonder is not a permission slip for certainty.
For now, the evidence points toward a modest conclusion. Use technology when it helps you do the things already known to protect health. Treat experimental longevity interventions as experiments. And remember that the final score is not a dashboard full of green numbers.
It is more healthy time.
Sources
- Li Y, et al. Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population. Circulation. 2018.
- Jha P, et al. 21st-Century Hazards of Smoking and Benefits of Cessation in the United States. New England Journal of Medicine. 2013.
- Moore SC, et al. Leisure Time Physical Activity of Moderate to Vigorous Intensity and Mortality. PLOS Medicine. 2012.
- Waziry R, et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nature Aging. 2023.
- Moqri M, et al. Validation of biomarkers of aging. Nature Medicine. 2024.
- Lee DJW, et al. Targeting ageing with rapamycin and its derivatives in humans: a systematic review. The Lancet Healthy Longevity. 2024.
- Kulkarni AS, et al. A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan. Frontiers in Endocrinology. 2020.
- US Food and Drug Administration. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes.
This article is for general information and is not personal medical advice.
